Acute myeloid leukemia, or AML, is a rare and aggressive cancer that can affect people of all ages. Recurrence rates in AML are also high and there is no one-size-fits-all treatment option, says Kiran Vanaja, assistant research professor in bioengineering at Northeastern University.
Please follow and like us:
